2-溴-3-甲基苯酚 | 22061-78-5

• 物质功能分类: 原料药 - 抑制剂
• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 2-溴-3-甲基苯酚
• 英文名称: 2-bromo-3-methylphenol
• CAS: 22061-78-5
• 化学式: C₇H₇BrO
• mdl: MFCD09991797
• 分子量: 187.036
• InChiKey: HUGNLEZLTOVJLD-UHFFFAOYSA-N

物化性质

• 熔点：
  58.5-59 °C
• 沸点：
  83-84 °C(Press: 4 Torr)
• 密度：
  1.554±0.06 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2908199090
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-3-methylphenol
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-3-methylphenol
CAS number: 22061-78-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H7BrO
Molecular weight: 187.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

概述

2-溴-3-甲基苯酚是一种苯酚类衍生物，可作为医药中间体使用。

产品用途

2-溴-3-甲基苯酚可用于制备一种代表性化合物，在细胞为基础的HIV复制测试中表现出抑制剂活性。该化合物能够抑制HIV整合酶的活性，从而有助于降低HIV的复制。

反应信息

• 作为反应物：
  描述：

  2-溴-3-甲基苯酚 在 正丁基锂 、 乙醚 作用下， 生成 2-羟基-6-甲基苯甲酸
  参考文献：
  名称：

  The Synthesis of 6-Formylsalicylic Acid, Esters of 6-Bromomethylsalicylic Acid, and Related Substances

  摘要：

  DOI：

  10.1021/jo50018a010
• 作为产物：
  描述：

  间甲酚 在 硫酸 、 溴 作用下， 生成 2-溴-3-甲基苯酚
  参考文献：
  名称：

  Jonkheer,P.C.T.M. et al., Recueil des Travaux Chimiques des Pays-Bas, 1978, vol. 97, p. 223 - 248

  摘要：

  DOI：

文献信息

• [EN] NOVEL THYROMIMETICS<br/>[FR] NOUVEAUX THYROMIMÉTIQUES
  申请人：AUTOBAHN THERAPEUTICS INC

  公开号：WO2021108549A1

  公开（公告）日：2021-06-03

  Compounds are provided having the structure of Formula (I) or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein R1, R2, X1, X2, Y1, and Y2 are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.

  提供具有Formula (I)结构或其药学上可接受的异构体、拉克酸盐、水合物、溶剂化合物、同位素或盐的化合物，其中R1、R2、X1、X2、Y1和Y2如本文所定义。这些化合物作为甲状腺类似物发挥作用，并可用于治疗神经退行性疾病和纤维化疾病等疾病。还提供含有这些化合物的药物组合物，以及它们的使用和制备方法。
• [EN] OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS OXADIAZINE ET LEURS MÉTHODES D'UTILISATION
  申请人：FORUM PHARMCEUTICALS INC

  公开号：WO2016201168A1

  公开（公告）日：2016-12-15

  The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.

  本公开涉及恶二嗪化合物，包含有效量的恶二嗪化合物的药物组合物，以及使用恶二嗪化合物治疗神经退行性疾病的方法，包括向需要其的受试者施用有效量的恶二嗪化合物。
• [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2009062289A1

  公开（公告）日：2009-05-22

  Compounds of formula I : wherein c, R2, R3, R4, R5, R6, R7 and R8 are defined herein, are useful as inhibitors of HIV replication.

  公式I的化合物：其中c、R2、R3、R4、R5、R6、R7和R8按本说明定义，可用作HIV复制的抑制剂。
• Regioselective Halogenation of Arenes and Heterocycles in Hexafluoroisopropanol
  作者：Ren-Jin Tang、Thierry Milcent、Benoit Crousse

  DOI：10.1021/acs.joc.7b02920

  日期：2018.1.19

  halogenation of arenes and heterocycles with N-halosuccinimides in fluorinated alcohols is disclosed. Under mild condition reactions, a wide diversity of halogenated arenes are obtained in good yields with high regioselectivity. Additionally, the versatility of the method is demonstrated by the development of one-pot sequential halogenation and halogenation-Suzuki cross-coupling reactions.

  公开了在氟化醇中用N-卤代琥珀酰亚胺对芳烃和杂环的区域选择性卤化。在温和的条件下反应，可以以高收率和高区域选择性获得各种各样的卤代芳烃。另外，该方法的多功能性通过一锅法连续卤化和卤化-Suzuki交叉偶联反应得到证明。
• GPR40 AGONISTS IN ANTI-DIABETIC DRUG COMBINATIONS
  申请人：Janssen Pharmaceutica NV

  公开号：US20170290800A1

  公开（公告）日：2017-10-12

  Disclosed are compositions comprising (a) a GPR40 agonist and (b) an SGLT2 inhibitor, and methods for treating of disorders that are affected by the modulation of the GPR40 receptor and SGLT2 transporter. Such GPR40 compounds are represented by Formula (I) as follows: wherein ring W, R 1 , R 2 , R 3 , R 5 , R 6 , A, and Z, are defined herein.

  本文披露了包含（a）GPR40激动剂和（b）SGLT2抑制剂的组合物，以及治疗受GPR40受体和SGLT2转运蛋白调节影响的疾病的方法。这些GPR40化合物由以下式（I）表示： 其中环W，R1，R2，R3，R5，R6，A和Z在此处被定义。

表征谱图